<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39396040</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2046-4053</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Systematic reviews</Title><ISOAbbreviation>Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Teledermatology: an evidence map of systematic reviews.</ArticleTitle><Pagination><StartPage>258</StartPage><MedlinePgn>258</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">258</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13643-024-02655-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although the number of teledermatology studies is increasing, not all variables have been researched in equal depth, so there remains a lack of robust evidence for some teledermatology initiatives. This review describes the landscape of teledermatology research and identifies knowledge gaps and research needs. This evidence map can be used to inform clinicians about the current knowledge about teledermatology and guide researchers for future studies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Our evidence map was conducted according to the Campbell Collaboration checklist for evidence and gap maps. Eight databases were searched (CINAHL, Embase, PubMed, Scopus, Web of Science, Cochrane Library, JBI Database of Systematic Reviews and Implementation Reports, and OpenGray), and only included systematic reviews of teledermatology involving humans published in English; while excluding non-systematic reviews (i.e., abstracts, conference proceedings, editorials, commentaries, or letters). From 909 records, 14 systematic reviews published between 2004 and 2022 were included. Our analysis focused on the systematic reviews' characteristics, dermatological conditions studied, rate of overlap and quality assessment of primary studies reviewed, and main findings reported.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Teledermatology was reportedly comparable with clinic dermatology and generally accepted by patients as a mode of care delivery for dermatological conditions. However, there are concerns about privacy, communication, completeness of information transmitted, familiarity with the technology, and technical problems. Healthcare professionals were generally satisfied with teledermatology but found telemedicine consultations longer than face-to-face consultations, and less confident in asynchronous teledermatology than conventional consultations. Teledermatology was reportedly more cost-effective than clinic dermatology; especially considering the distance traveled by patients, referral volume to teledermatology, and clinic dermatology costs. Although patients and providers are satisfied with teledermatology, face-to-face dermatology has higher diagnostic and management accuracy. Teledermatology was also used for training medical professionals. Regarding the validity and reliability of teledermatology outcome measures, no significant discussions were found.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">COVID-19 spotlighted telemedicine in clinical care, and we must ensure telemedicine continually improves with robust research. Further research is necessary for establishing a standardized outcome set, enhancing accuracy, concordance, cost-effectiveness, and safety, comparing teledermatology with non-dermatologist care, examining its effectiveness in non-Western low and middle-income countries, and incorporating patient involvement for improved study design.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="BACKGROUND">https://www.researchregistry.com/ (Unique Identifying Number: reviewregistry878).</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Aloysius</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2377-4506</Identifier><AffiliationInfo><Affiliation>Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Helen Elizabeth</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Keele University, Staffordshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Car</LastName><ForeName>Lorainne Tudor</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Jing Wen</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>National Healthcare Group Polyclinics, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choo</LastName><ForeName>Kay Wee</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>A Life Clinic Pte Ltd, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aw</LastName><ForeName>Angeline Ai Ling</ForeName><Initials>AAL</Initials><AffiliationInfo><Affiliation>Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Marie Ann Mae En</ForeName><Initials>MAME</Initials><AffiliationInfo><Affiliation>Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfelbacher</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore. christian.apfelbacher@med.ovgu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Leipziger Str. 44, Bldg 2, office 120, Magdeburg, 39120, Germany. christian.apfelbacher@med.ovgu.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Syst Rev</MedlineTA><NlmUniqueID>101580575</NlmUniqueID><ISSNLinking>2046-4053</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003880" MajorTopicYN="Y">Dermatology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012871" MajorTopicYN="Y">Skin Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dermatology</Keyword><Keyword MajorTopicYN="N">Evidence map</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Teledermatology</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword></KeywordList><CoiStatement>CA received institutional funding from the Dr. Wolff Group and Bionorica, and consultancy fees from the Dr. Wolff Group, Sanofi, Incyte, Bionorica, and LEO Pharma. All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39396040</ArticleId><ArticleId IdType="pmc">PMC11476646</ArticleId><ArticleId IdType="doi">10.1186/s13643-024-02655-5</ArticleId><ArticleId IdType="pii">10.1186/s13643-024-02655-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pak H, Lee IA, Whited JD. Teledermatology. In: Rheuban KS, Krupinski EA, editors. Understanding Telehealth. New York, NY: McGraw-Hill Education; 2018. p. 113–24.</Citation></Reference><Reference><Citation>Beer J, Hadeler E, Calume A, Gitlow H, Nouri K. Teledermatology: current indications and considerations for future use. Arch Dermatol Res. 2021;313:11–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7570421</ArticleId><ArticleId IdType="pubmed">33074356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi MG, Santos A, Cordioli E. Benefits of teledermatology for geriatric patients: population-based cross-sectional study. J Med Internet Res. 2020;22(4):e16700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201316</ArticleId><ArticleId IdType="pubmed">32314966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehris RP, Herman EI. Pediatric teledermatology: a review. Curr Dermatol Rep. 2020;9:114–22.</Citation></Reference><Reference><Citation>Schafrank LA, Falkner RC, Lam TK, Meyerle JH. Teledermatology in military settings. Curr Dermatol Rep. 2021;10:33–9.</Citation></Reference><Reference><Citation>Armstrong AW, Kwong MW, Ledo L, Nesbitt TS, Shewry SL. Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists. PLoS One. 2011;6(12):e28687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3237480</ArticleId><ArticleId IdType="pubmed">22194887</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnane A, Siller G, Mujcic R, Soyer HP. The growth of a skin emergency teledermatology service from 2008 to 2014. Australas J Dermatol. 2016;57(1):14–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26559493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashshur RL, Shannon GW, Tejasvi T, Kvedar JC, Gates M. The empirical foundations of teledermatology: a review of the research evidence. Telemed E Health. 2015;21(12):953–79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4776540</ArticleId><ArticleId IdType="pubmed">26394022</ArticleId></ArticleIdList></Reference><Reference><Citation>Snoswell C, Finnane A, Janda M, Soyer HP, Whitty JA. Cost-effectiveness of store-and-forward teledermatology: a systematic review. JAMA Dermatol. 2016;152(6):702–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Whited JD. Economic analysis of telemedicine and the teledermatology paradigm. Telemed E Health. 2010;16(2):223–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20136558</ArticleId></ArticleIdList></Reference><Reference><Citation>White H, Albers B, Gaarder M, Kornør H, Littell J, Marshall Z, et al. Guidance for producing a Campbell evidence and gap map. Campbell Syst Rev. 2020;16(4):e1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356343</ArticleId><ArticleId IdType="pubmed">37016607</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018;18(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5761190</ArticleId><ArticleId IdType="pubmed">29316881</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters MD, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–26.</Citation><ArticleIdList><ArticleId IdType="pubmed">33038124</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieper D, Antoine S-L, Mathes T, Neugebauer EA, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67(4):368–75.</Citation><ArticleIdList><ArticleId IdType="pubmed">24581293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracchiglione J, Meza N, Bangdiwala SI, Niño de Guzmán E, Urrútia G, Bonfill X, Madrid E. Graphical representation of overlap for overviews: GROOVE tool. Res Synth Methods. 2022;13(3):381–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35278030</ArticleId></ArticleIdList></Reference><Reference><Citation>Demiris G, Speedie SM, Hicks LL. Assessment of patients’ acceptance of and satisfaction with teledermatology. J Med Syst. 2004;28(6):575–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15615285</ArticleId></ArticleIdList></Reference><Reference><Citation>Eminović N, De Keizer N, Bindels P, Hasman A. Maturity of teledermatology evaluation research: a systematic literature review. Br J Dermatol. 2007;156(3):412–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17300227</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heijden JP, Spuls PI, Voorbraak FP, de Keizer NF, Witkamp L, Bos JD. Tertiary teledermatology: a systematic review. Telemed E Health. 2010;16(1):56–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20064068</ArticleId></ArticleIdList></Reference><Reference><Citation>Warshaw EM, Hillman YJ, Greer NL, Hagel EM, MacDonald R, Rutks IR, et al. Teledermatology for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol. 2011;64(4):759-72. e21.</Citation><ArticleIdList><ArticleId IdType="pubmed">21036419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace D, Hussain A, Khan N, Wilson Y. A systematic review of the evidence for telemedicine in burn care: with a UK perspective. Burns. 2012;38(4):465–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078804</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark AK, Bosanac S, Ho B, Sivamani RK. Systematic review of mobile phone-based teledermatology. Arch Dermatol Res. 2018;310(9):675–89.</Citation><ArticleIdList><ArticleId IdType="pubmed">30250964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuchu N, Dinnes J, Takwoingi Y, Matin RN, Bayliss SE, Davenport C, et al. Teledermatology for diagnosing skin cancer in adults. Cochrane Database Syst Rev. 2018;12:CD013193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6517019</ArticleId><ArticleId IdType="pubmed">30521686</ArticleId></ArticleIdList></Reference><Reference><Citation>Trettel A, Eissing L, Augustin M. Telemedicine in dermatology: findings and experiences worldwide–a systematic literature review. J Eur Acad Dermatol Venereol. 2018;32(2):215–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">28516492</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuertes-Guiro F, Girabent-Farrés M. Opportunity cost of the dermatologist’s consulting time in the economic evaluation of teledermatology. J Telemed Telecare. 2017;23(7):657–64.</Citation><ArticleIdList><ArticleId IdType="pubmed">27450572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounessa JS, Chapman S, Braunberger T, Qin R, Lipoff JB, Dellavalle RP, et al. A systematic review of satisfaction with teledermatology. J Telemed Telecare. 2018;24(4):263–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28350281</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsner P. Teledermatology in the times of COVID-19–a systematic review. J Dtsch Dermatol Ges. 2020;18(8):841–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33448667</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh CH, Tam SYC, Oh CC. Teledermatology in the COVID-19 pandemic: a systematic review. JAAD Int. 2021;5:54–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326016</ArticleId><ArticleId IdType="pubmed">34368789</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J, Jones E. Shaping the future of teledermatology: a literature review of patient and provider satisfaction with synchronous teledermatology during the COVID-19 pandemic. Clin Exp Dermatol. 2022;47(11):1903–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349528</ArticleId><ArticleId IdType="pubmed">35775880</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group* P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Şenel E, Demir E. A global productivity and bibliometric analysis of telemedicine and teledermatology publication trends during 1980–2013. Dermatol Sin. 2015;33(1):16–20.</Citation></Reference><Reference><Citation>Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, et al. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set”–a practical guideline. Trials. 2016;17(1):1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020549</ArticleId><ArticleId IdType="pubmed">27618914</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>